Interaction between treg apoptosis pathways, treg function and HLA risk evolves during type 1 diabetes pathogenesis

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Glisic, Sanja ^a   Jailwala, Parthav ^b  

^a Children's Hospital of Wisconsin   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; GROWTH HORMONE; HLA ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR; FADD PROTEIN, HUMAN; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA-DQA1 ANTIGEN; HLA-DQB1 ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; ASSAY; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETOGENESIS; DISEASE COURSE; EVOLUTION; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETICS; GENOMICS; HLA SYSTEM; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; MALE; OXIDATIVE STRESS; REGULATORY T LYMPHOCYTE; RISK ASSESSMENT; SIGNAL TRANSDUCTION; GENOTYPE; IMMUNOLOGY; METABOLISM; MITOCHONDRION; PATHOLOGY; RISK;

ANTIGENS, CD95; APOPTOSIS; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENOTYPE; GROWTH HORMONE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ALPHA-CHAINS; HLA-DQ BETA-CHAINS; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; RECEPTORS, TUMOR NECROSIS FACTOR; RISK; T-LYMPHOCYTES, REGULATORY;

EID: 84860365184     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036040     Document Type: Article

References (76)

1. Dabelea D, Bell RA, D'Agostino RB Jr, Imperatore G, Johansen JM, et al. (2007) Incidence of diabetes in youth in the United States. JAMA 297: 2716-2724.
2. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J, (1999) Worldwide increase in incidence of Type I diabetes-the analysis of the data on published incidence trends. Diabetologia 42: 1395-1403.
3. Todd JA, Bell JI, McDevitt HO, (1987) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604.
4. Thorsby E, Ronningen KS, (1993) Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 371-377.
5. Todd JA, (1990) The role of MHC class II genes in susceptibility to insulin-dependent diabetes mellitus. Curr Top Microbiol Immunol 164: 17-40.
6. Brown WM, Pierce J, Hilner JE, Perdue LH, Lohman K, et al. (2009) Overview of the MHC fine mapping data. Diabetes Obes Metab 11 (Suppl 1): 2-7.
7. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, et al. (1996) The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 59: 1134-1148.
8. Nejentsev S, Gombos Z, Laine AP, Veijola R, Knip M, et al. (2000) Non-class II HLA gene associated with type 1 diabetes maps to the 240 kb region near HLA-B. Diabetes 49: 2217-2221.
9. Nerup J, Platz P, Andersen OO, Christy M, Lyngsoe J, et al. (1974) HL-A antigens and diabetes mellitus. Lancet 2: 864-866.
10. Rotter JI, Landaw EM, (1984) Measuring the genetic contribution of a single locus to a multilocus disease. Clin Genet 26: 529-542.
11. de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, et al. (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 38: 1166-1172.
12. She JX, (1996) Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 17: 323-329.
13. Pociot F, McDermott MF, (2002) Genetics of type 1 diabetes mellitus. Genes Immun 3: 235-249.
14. Kwok WW, Domeier ME, Johnson ML, Nepom GT, Koelle DM, (1996) HLA-DQB1 codon 57 is critical for peptide binding and recognition. J Exp Med 183: 1253-1258.
15. Cucca F, Lampis R, Congia M, Angius E, Nutland S, et al. (2001) A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 10: 2025-2037.
16. Kansas GS, Tedder TF, (1991) Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. J Immunol 147: 4094-4102.
17. Mooney NA, Grillot-Courvalin C, Hivroz C, Ju LY, Charron D, (1990) Early biochemical events after MHC class II-mediated signaling on human B lymphocytes. J Immunol 145: 2070-2076.
18. Mascle F, Mooney N, Devergie A, Gluckman E, Charron D, (1990) Role of HLA class II molecules expressed on hematopoietic progenitor cells. Nouv Rev Fr Hematol 32: 333-335.
19. Thibeault A, Zekki H, Mourad W, Charron D, Al-Daccak R, (1999) Triggering HLA-DR molecules on human peripheral monocytes induces their death. Cell Immunol 192: 79-85.
20. Vincent R, Louis P, Gongora C, Papa I, Clot J, et al. (1996) Quantitative analysis of the expression of the HLA-DRB genes at the transcriptional level by competitive polymerase chain reaction. J Immunol 156: 603-610.
21. Morzycka-Wroblewska E, Munshi A, Ostermayer M, Harwood JI, Kagnoff MF, (1997) Differential expression of HLA-DQA1 alleles associated with promoter polymorphism. Immunogenetics 45: 163-170.
22. Ferstl B, Zacher T, Lauer B, Blagitko-Dorfs N, Carl A, et al. (2004) Allele-specific quantification of HLA-DQB1 gene expression by real-time reverse transcriptase-polymerase chain reaction. Genes Immun 5: 405-416.
23. Redondo MJ, Fain PR, Eisenbarth GS, (2001) Genetics of type 1A diabetes. Recent Prog Horm Res 56: 69-89.
24. Gorus FK, (1996) The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus. Verh K Acad Geneeskd Belg 58: 539-586.
25. Valdes AM, Wapelhorst B, Concannon P, Erlich HA, Thomson G, et al. (2005) Extended DR3-D6S273-HLA-B haplotypes are associated with increased susceptibility to type 1 diabetes in US Caucasians. Tissue Antigens 65: 115-119.
26. Erlich HA, Griffith RL, Bugawan TL, Ziegler R, Alper C, et al. (1991) Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes. Diabetes 40: 478-481.
27. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, et al. (1990) Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322: 1836-1841.
28. Greenbaum CJ, Gaur LK, Noble JA, (2002) ICA+ relatives with DQA1*0102/DQB1*0602 have expected 0602 sequence and DR types. J Autoimmun 18: 67-70.
29. Nepom GT, Kwok WW, (1998) Molecular basis for HLA-DQ associations with IDDM. Diabetes 47: 1177-1184.
30. Glisic S, Klinker M, Waukau J, Jailwala P, Jana S, et al. (2009) Genetic association of HLA DQB1 with CD4+CD25+(high) T-cell apoptosis in type 1 diabetes. Genes Immun 10: 334-340.
31. Lie BA, Todd JA, Pociot F, Nerup J, Akselsen HE, et al. (1999) The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet 64: 793-800.
32. Alberti KG, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
33. Glisic-Milosavljevic S, Waukau J, Jailwala P, Jana S, Khoo HJ, et al. (2007) At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction. PLoS ONE 2: e146.
34. Shookster L, Matsuyama T, Burmester G, Winchester R, (1987) Monoclonal antibody 1a3 recognizes a monomorphic epitope unique to DQ molecules. Hum Immunol 20: 59-70.
35. Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, et al. (2003) New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 62: 296-307.
36. Jailwala P, Waukau J, Glisic S, Jana S, Ehlenbach S, et al. (2009) Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation. PLoS ONE 4: e6527.
37. Holling TM, van der Stoep N, Quinten E, van den Elsen PJ, (2002) Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III. J Immunol 168: 763-770.
38. Wyss-Coray T, Brander C, Bettens F, Mijic D, Pichler WJ, (1992) Use of antibody/peptide constructs of direct antigenic peptides to T cells: evidence for T cell processing and presentation. Cell Immunol 139: 268-273.
39. LaSalle JM, Ota K, Hafler DA, (1991) Presentation of autoantigen by human T cells. J Immunol 147: 774-780.
40. Hewitt CR, Feldmann M, (1989) Human T cell clones present antigen. J Immunol 143: 762-769.
41. Barnaba V, Watts C, de Boer M, Lane P, Lanzavecchia A, (1994) Professional presentation of antigen by activated human T cells. Eur J Immunol 24: 71-75.
42. Baecher-Allan C, Wolf E, Hafler DA, (2006) MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 176: 4622-4631.
43. Benoist C, Mathis D, (1990) Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 8: 681-715.
44. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, et al. (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375-387.
45. Reinisch W, Lichtenberger C, Steger G, Tillinger W, Scheiner O, et al. (2003) Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo. Clin Exp Immunol 133: 476-484.
46. Kato-Kogoe N, Ohyama H, Nishimura F, Meguro M, Yoshizawa S, et al. (2010) Fibroblasts stimulated via HLA-II molecules produce prostaglandin E and regulate cytokine production from helper T cells. Lab Invest 90: 1747-1756.
47. Donner H, Seidl C, Rau H, Herwig J, Seifried E, et al. (2002) Unbalanced amounts of HLA-DQA1 allele mRNA: DQA1*03 shows high and DQA1*0501 low amounts of mRNA in heterozygous individuals. Eur J Immunogenet 29: 321-330.
48. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, et al. (2005) MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37: 486-494.
49. Bonzon C, Bouchier-Hayes L, Pagliari LJ, Green DR, Newmeyer DD, (2006) Caspase-2-induced apoptosis requires bid cleavage: a physiological role for bid in heat shock-induced death. Mol Biol Cell 17: 2150-2157.
50. Sood SK, Balasubramanian S, Higham S, Fernando M, Harrison B, (2011) Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. World J Surg 35: 1984-1992.
51. Collin-Osdoby P, Rothe L, Anderson F, Nelson M, Maloney W, et al. (2001) Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem 276: 20659-20672.
52. Yun TJ, Tallquist MD, Aicher A, Rafferty KL, Marshall AJ, et al. (2001) Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. J Immunol 166: 1482-1491.
53. Yun TJ, Chaudhary PM, Shu GL, Frazer JK, Ewings MK, et al. (1998) OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol 161: 6113-6121.
54. Stehlik C, Hayashi H, Pio F, Godzik A, Reed JC, (2003) CARD6 is a modulator of NF-kappa B activation by Nod1- and Cardiak-mediated pathways. J Biol Chem 278: 31941-31949.
55. Fang HY, Chen CY, Hung MF, Hsiao YT, Chiang TC, et al. (2011) Caspase-14 is an anti-apoptotic protein targeting apoptosis-inducing factor in lung adenocarcinomas. Oncol Rep 26: 359-369.
56. Cowburn AS, Summers C, Dunmore BJ, Farahi N, Hayhoe RP, et al. (2011) Granulocyte/macrophage colony-stimulating factor causes a paradoxical increase in the BH3-only pro-apoptotic protein Bim in human neutrophils. Am J Respir Cell Mol Biol 44: 879-887.
57. Xiang J, Chao DT, Korsmeyer SJ, (1996) BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci U S A 93: 14559-14563.
58. Rhoads DM, Umbach AL, Subbaiah CC, Siedow JN, (2006) Mitochondrial reactive oxygen species. Contribution to oxidative stress and interorganellar signaling. Plant Physiol 141: 357-366.
59. Rains JL, Jain SK, (2011) Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50: 567-575.
60. Taplin CE, Barker JM, (2008) Autoantibodies in type 1 diabetes. Autoimmunity 41: 11-18.
61. Sohn D, Budach W, Janicke RU, (2011) Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21(WAF1/CIP1). Cell Death Differ 18: 1664-1674.
62. Yamamoto T, Maruyama W, Kato Y, Yi H, Shamoto-Nagai M, et al. (2002) Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells. J Neural Transm 109: 1-13.
63. Robertson LA, Kim AJ, Werstuck GH, (2006) Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3. Can J Physiol Pharmacol 84: 39-48.
64. Zhang K, Shen X, Wu J, Sakaki K, Saunders T, et al. (2006) Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 124: 587-599.
65. Wei Y, Wang D, Topczewski F, Pagliassotti MJ, (2006) Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 291: E275-281.
66. Ishola DA Jr, Post JA, van Timmeren MM, Bakker SJ, Goldschmeding R, et al. (2006) Albumin-bound fatty acids induce mitochondrial oxidant stress and impair antioxidant responses in proximal tubular cells. Kidney Int 70: 724-731.
67. Scheuner D, Vander Mierde D, Song B, Flamez D, Creemers JW, et al. (2005) Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis. Nat Med 11: 757-764.
68. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, et al. (2002) High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16: 1738-1748.
69. Eizirik DL, Cardozo AK, Cnop M, (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29: 42-61.
70. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, et al. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84.
71. Li H, Zhu H, Xu CJ, Yuan J, (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501.
72. Mauro C, Crescenzi E, De Mattia R, Pacifico F, Mellone S, et al. (2006) Central role of the scaffold protein tumor necrosis factor receptor-associated factor 2 in regulating endoplasmic reticulum stress-induced apoptosis. J Biol Chem 281: 2631-2638.
73. Shen HM, Lin Y, Choksi S, Tran J, Jin T, et al. (2004) Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death. Mol Cell Biol 24: 5914-5922.
74. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, et al. (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287: 664-666.
75. Himer L, Csoka B, Selmeczy Z, Koscso B, Pocza T, et al. (2010) Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death. FASEB J 24: 2631-2640.
76. Fritzsching B, Oberle N, Eberhardt N, Quick S, Haas J, et al. (2005) In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J Immunol 175: 32-36.